SOC Telemed, Inc. provides acute care telemedicine services and technology to hospitals, health systems, physician groups, and government organizations in the United States. The company's technology platform, Telemed IQ, provides telemedicine programs. Its telemedicine solutions include teleNeurology, telePulmonology, telePsychiatry, and teleICU. The company was founded in 2004 and is based in Reston, Virginia.
IPO Year: 2020
Exchange: NASDAQ
Website: soctelemed.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/1/2022 | $3.00 | Neutral | Credit Suisse |
| 2/7/2022 | $2.00 → $3.00 | Neutral | Credit Suisse |
| 2/4/2022 | Buy → Hold | Benchmark | |
| 2/3/2022 | $6.00 → $3.00 | Outperform → Sector Perform | RBC Capital |
| 2/3/2022 | $4.00 → $3.00 | Outperform → Neutral | Baird |
| 1/7/2022 | $6.00 → $2.00 | Outperform → Neutral | Credit Suisse |
| 8/13/2021 | $10.00 → $6.00 | Outperform | RBC Capital |
| 8/13/2021 | $11.00 → $8.50 | Outperform | Credit Suisse |
SC 13D/A - SOC Telemed, Inc. (0001791091) (Subject)
SC 13G - SOC Telemed, Inc. (0001791091) (Subject)
SC 13G/A - SOC Telemed, Inc. (0001791091) (Subject)
SC 13G/A - SOC Telemed, Inc. (0001791091) (Subject)
SC 13G/A - SOC Telemed, Inc. (0001791091) (Subject)
SC 13G - SOC Telemed, Inc. (0001791091) (Subject)
SC 13D/A - SOC Telemed, Inc. (0001791091) (Subject)
SC 13G - SOC Telemed, Inc. (0001791091) (Subject)
SC 13G - SOC Telemed, Inc. (0001791091) (Subject)
SC 13D/A - SOC Telemed, Inc. (0001791091) (Subject)
Credit Suisse resumed coverage of SOC Telemed with a rating of Neutral and set a new price target of $3.00
Credit Suisse reiterated coverage of SOC Telemed with a rating of Neutral and set a new price target of $3.00 from $2.00 previously
Benchmark downgraded SOC Telemed from Buy to Hold
RBC Capital downgraded SOC Telemed from Outperform to Sector Perform and set a new price target of $3.00 from $6.00 previously
Baird downgraded SOC Telemed from Outperform to Neutral and set a new price target of $3.00 from $4.00 previously
Credit Suisse downgraded SOC Telemed from Outperform to Neutral and set a new price target of $2.00 from $6.00 previously
RBC Capital reiterated coverage of SOC Telemed with a rating of Outperform and set a new price target of $6.00 from $10.00 previously
Credit Suisse reiterated coverage of SOC Telemed with a rating of Outperform and set a new price target of $8.50 from $11.00 previously
Robert W. Baird initiated coverage of SOC Telemed with a rating of Outperform and set a new price target of $8.00
Baird initiated coverage of SOC Telemed with a rating of Outperform and set a new price target of $7.50
Veteran Legal Executive Brings More Than Two Decades of Experience in Private and Public Sector Regulatory Affairs, Ethics and Compliance to Unified Defense SIEM Leader Securonix, Inc., a leader in Unified Defense SIEM, today announced the appointment of Eunice Kim as general counsel. In this role, Kim will be responsible for leading Securonix's legal and compliance functions, enhancing processes for evaluating expansion and growth opportunities, and implementing corporate policies that support the company's mission, vision and values. "Eunice is a dynamic legal executive, and we are thrilled to welcome her to Securonix," said Nayaki Nayyar, Chief Executive Officer, Securonix. "Her prov
HERNDON, Va., April 6, 2022 /PRNewswire/ -- SOC Telemed, Inc. (NASDAQ:TLMD) (the "Company" or "SOC Telemed"), the largest national provider of acute care telemedicine, today announced the completion of its previously announced transaction to be acquired by Patient Square Capital, a leading dedicated health care investment firm, in an all-cash transaction. The acquisition was previously announced on February 3, 2022, and SOC Telemed's stockholders approved the transaction at the Special Meeting of Stockholders held on April 4, 2022. Upon completion of the acquisition, SOC Telemed stockholders received $3.00 in cash per share of Class A common stock. SOC Telemed's Class A common stock and warr
HERNDON, Va., April 4, 2022 /PRNewswire/ -- SOC Telemed, Inc. (NASDAQ:TLMD) (the "Company" or "SOC Telemed"), the largest national provider of acute care telemedicine, today announced that its stockholders approved the acquisition of SOC Telemed by Patient Square Capital, a leading dedicated health care investment firm, at a special meeting. Steve Shulman, Chairman of the SOC Telemed Board of Directors, said, "On behalf of the SOC Telemed Board, I would like to thank our stockholders for their support of this transaction. Today's vote represents an important milestone towards
Revenue of $28.0 million in the fourth quarter an increase of 93% year over year Revenue of $94.4 million in 2021 an increase of 63% year over year Bookings of $7.8 million in the fourth quarter an increase of 100% year over year Bookings of $31.8 million in 2021 an increase of 162% year over year Announced take private acquisition by Patient Square Capital for $3 per share in cash RESTON, Va., March 30, 2022 /PRNewswire/ -- SOC Telemed, Inc., (NASDAQ:TLMD), the largest national provider of acute care telemedicine, today announced its financial and operating results for the fourth quarter and full year ending December 31, 2021.
HERNDON, Va., Feb. 3, 2022 /PRNewswire/ -- SOC Telemed, Inc. (NASDAQ:TLMD) (the "Company" or "SOC Telemed"), the largest national provider of acute care telemedicine, today announced that it has entered into a definitive agreement to be acquired by Patient Square Capital ("Patient Square"), the leading dedicated health care investment firm. Under the terms of the agreement, SOC Telemed stockholders will receive $3.00 in cash per share of Class A common stock ("the common stock"). The per share purchase price represents a premium of approximately 366.1% over SOC Telemed's clos
RESTON, Va., Nov. 12, 2021 /PRNewswire/ -- SOC Telemed, Inc., (NASDAQ:TLMD), the largest national provider of acute care telemedicine, today announced its financial and operating results for the third quarter ending September 30, 2021. SOC Telemed Reports Third Quarter 2021 Financial and Operating Results "We are proud of our third quarter results as the new organization came together with renewed focus resulting in the highest quarterly revenue and bookings in our company's history," said Dr. Chris Gallagher, Chief Executive Officer. "Upon joining the Company, my first task h
RESTON, Va., Oct. 29, 2021 /PRNewswire/ -- SOC Telemed, Inc. (NASDAQ:TLMD), the largest national provider of acute care telemedicine, today announced that the company will provide a corporate and financial update for the third quarter 2021, on Friday, November 12, 2021, before market open. SOC Telemed's management team will host a conference call and live audio webcast at 8:00 a.m. ET. To participate in the call, dial either the domestic or international number or join the webcast from your computer or mobile phone. Domestic: (877) 292-0959 International: (412) 542-4143 Passco
RESTON, Va., Sept. 16, 2021 /PRNewswire/ -- SOC Telemed (NASDAQ:TLMD), the largest national provider of acute care telemedicine, and Ob Hospitalist Group (OBHG), the nation's largest and only dedicated provider of customized obstetric (OB) hospitalist programs, today announced a collaboration combining OBHG's leading OB hospitalist programs with SOC Telemed's maternal-fetal medicine (MFM) experts. The first hospital partner to go live with the new service in early August 2021 was Hendrick Medical Center in Abilene, Texas. The combined OB hospitalist/teleMFM offering is currently expanding to additional OBHG hospital partner sites nationwide.
RESTON, Va., Sept. 15, 2021 /PRNewswire/ -- SOC Telemed, Inc. (NASDAQ:TLMD, ", SOC", ))), the largest national provider of acute care telemedicine, today announced that Chris Knibb, Chief Financial Officer (CFO), has resigned to pursue other opportunities effective September 23, 2021. The Company will immediately begin a search for a new CFO. David Fletcher has been appointed interim CFO, while SOC searches to identify a successor. Mr. Knibb will be available to support the transition through December 31, 2021. "I appreciate Chris' leadership and impact on the SOC team," said
RESTON, Va., Sept. 7, 2021 /PRNewswire/ -- SOC Telemed, Inc. (NASDAQ:TLMD), the largest national provider of acute care telemedicine, today announced that the Company will host an introductory conference call with new leadership, which was announced on September 1, 2021. Dr. Chris Gallagher, CEO of the Company, and Joe Greskoviak, Vice Chairman of the Board of Directors, will host the call on Thursday, September 9, 2021, at 5 p.m. ET. Dial-In Numbers Domestic: (877) 292-0959 International: (412) 542-4143 Passcode: please ask to join the SOC Telemed call A live audio webcast w
PRINCETON, N.J.--(BUSINESS WIRE)--CitiusTech, a leading provider of healthcare technology services and solutions, announced today that Anne McGeorge, former Managing Partner of Grant Thornton’s Global Health Care and Life Sciences Practices, has joined its Board of Directors and chair of the Audit Committee. Ms. McGeorge comes with over 35 years of experience advising healthcare clients in all aspects of finance and transformational change, including strategy, M&A, joint ventures, financial statement audits, corporate restructuring, governance, talent acquisition, executive compensation, IRS matters and risk management. She created the healthcare / life sciences practice for Gran
4 - SOC Telemed, Inc. (0001791091) (Issuer)
4 - SOC Telemed, Inc. (0001791091) (Issuer)
4 - SOC Telemed, Inc. (0001791091) (Issuer)
4 - SOC Telemed, Inc. (0001791091) (Issuer)
4 - SOC Telemed, Inc. (0001791091) (Issuer)
4 - SOC Telemed, Inc. (0001791091) (Issuer)
4 - SOC Telemed, Inc. (0001791091) (Issuer)
4 - SOC Telemed, Inc. (0001791091) (Issuer)
4 - SOC Telemed, Inc. (0001791091) (Issuer)
4 - SOC Telemed, Inc. (0001791091) (Issuer)
RESTON, Va., Nov. 12, 2021 /PRNewswire/ -- SOC Telemed, Inc., (NASDAQ:TLMD), the largest national provider of acute care telemedicine, today announced its financial and operating results for the third quarter ending September 30, 2021. SOC Telemed Reports Third Quarter 2021 Financial and Operating Results "We are proud of our third quarter results as the new organization came together with renewed focus resulting in the highest quarterly revenue and bookings in our company's history," said Dr. Chris Gallagher, Chief Executive Officer. "Upon joining the Company, my first task h
RESTON, Va., Oct. 29, 2021 /PRNewswire/ -- SOC Telemed, Inc. (NASDAQ:TLMD), the largest national provider of acute care telemedicine, today announced that the company will provide a corporate and financial update for the third quarter 2021, on Friday, November 12, 2021, before market open. SOC Telemed's management team will host a conference call and live audio webcast at 8:00 a.m. ET. To participate in the call, dial either the domestic or international number or join the webcast from your computer or mobile phone. Domestic: (877) 292-0959 International: (412) 542-4143 Passco
RESTON, Va., Sept. 7, 2021 /PRNewswire/ -- SOC Telemed, Inc. (NASDAQ:TLMD), the largest national provider of acute care telemedicine, today announced that the Company will host an introductory conference call with new leadership, which was announced on September 1, 2021. Dr. Chris Gallagher, CEO of the Company, and Joe Greskoviak, Vice Chairman of the Board of Directors, will host the call on Thursday, September 9, 2021, at 5 p.m. ET. Dial-In Numbers Domestic: (877) 292-0959 International: (412) 542-4143 Passcode: please ask to join the SOC Telemed call A live audio webcast w
RESTON, Va., Sept. 1, 2021 /PRNewswire/ -- SOC Telemed, Inc. (NASDAQ:TLMD), the largest national provider of acute care telemedicine, today announced the appointment of a new leadership team and organization-wide realignment designed to accelerate growth, drive operational effectiveness and efficiencies, and ensure the highest levels of client success. With these changes, SOC Telemed is well positioned to respond to evolving industry demand for specialty telemedicine services, while continuing to innovate solutions which optimize clinical, operational, and financial performance. The Board appointed board member Chris Gallagher, MD, as Chief Executive Officer effective immediately, repla
15-12B - SOC Telemed, Inc. (0001791091) (Filer)
EFFECT - SOC Telemed, Inc. (0001791091) (Filer)
EFFECT - SOC Telemed, Inc. (0001791091) (Filer)
POS AM - SOC Telemed, Inc. (0001791091) (Filer)
POS AM - SOC Telemed, Inc. (0001791091) (Filer)
S-8 POS - SOC Telemed, Inc. (0001791091) (Filer)
RW - SOC Telemed, Inc. (0001791091) (Filer)
25-NSE - SOC Telemed, Inc. (0001791091) (Subject)
8-K - SOC Telemed, Inc. (0001791091) (Filer)
DEFA14A - SOC Telemed, Inc. (0001791091) (Filer)